Abstract PS10-10: Ribociclib + letrozole in premenopausal patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) advanced breast cancer (ABC): Subgroup analysis of the phase IIIb CompLEEment-1 trial

Authors: Hikmat Abdel Razeq, Paul Cottu, Alistair Ring, Michelino De Laurentiis, Janice Lu, Hamdy Azim, Claudio Zamagni, Katie Zhou, Jiwen Wu, Lakshmi Menon-Singh, Miguel Martín

Published: 2021-02-15

DOI: 10.1158/1538-7445.sabcs20-ps10-10

Source: Full article